27Sep/13

Decks clear for Mylan's $1.6 bn purchase of Bangalore-based Agila – Indian Express


Indian Express

Decks clear for Mylan’s $1.6 bn purchase of Bangalore-based Agila
Indian Express
Generic drugmaker Mylan Inc has won U.S. antitrust approval to buy Agila, a unit of India’s Strides Arcolab Ltd, subject to divesting some products, the Federal Trade Commission said on Thursday. India’s cabinet approved the deal on September 3.
FTC Asks Mylan, Agila To Divest 11 Drugs To Approve AcquisitionNASDAQ
U.S. approves Mylan’s purchase of Bangalore-based Agila, with conditionsBusiness Standard

all 11 news articles »

26Sep/13

US approves Mylan's purchase of Strides unit, with conditions – Reuters

US approves Mylan’s purchase of Strides unit, with conditions
Reuters
O) has won U.S. antitrust approval to buy Agila, a unit of India’s Strides Arcolab Ltd (STAR. The deal for Agila, which is based in the southern Indian city of Bangalore, was valued at $1.6 billion when it was announced in February. cancer drug
U.S. approves Mylan’s purchase of Bangalore-based Agila, with conditionsBusiness Standard

all 8 news articles »